The Moving Average Convergence Divergence (MACD) for BMA turned positive on November 03, 2026. Looking at past instances where BMA's MACD turned positive, the stock continued to rise in 39 of 41 cases over the following month. The odds of a continued upward trend are 90%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where BMA's RSI Oscillator exited the oversold zone, 22 of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a +2.24% 3-day Advance, the price is estimated to grow further. Considering data from situations where BMA advanced for three days, in 235 of 294 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
BMA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on October 26, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BMA as a result. In 66 of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 76%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.
The Aroon Indicator for BMA entered a downward trend on November 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is 1 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 2 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 56, placing this stock better than average.
The Tickeron Valuation Rating of 15 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: BMA's P/B Ratio (0.001) is slightly lower than the industry average of (1.271). P/E Ratio (0.001) is within average values for comparable stocks, (13.500). Projected Growth (PEG Ratio) (0.520) is also within normal values, averaging (1.190). Dividend Yield (0.032) settles around the average of (0.036) among similar stocks. BMA's P/S Ratio (1.824) is slightly lower than the industry average of (3.738).
The Tickeron Price Growth Rating for this company is 76 (best 1 - 100 worst), indicating slightly worse than average price growth. BMA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The 10-day moving average for NU crossed bearishly below the 50-day moving average on October 27, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 81%.
The Momentum Indicator moved below the 0 level on October 19, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NU as a result. In 57 of 79 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 72%.
The Moving Average Convergence Divergence Histogram (MACD) for NU turned negative on October 22, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In 27 of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at 64%.
NU moved below its 50-day moving average on October 26, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NU declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.
The Aroon Indicator for NU entered a downward trend on October 08, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +16.61% 3-day Advance, the price is estimated to grow further. Considering data from situations where NU advanced for three days, in 231 of 300 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
NU may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron SMR rating for this company is 5 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 74 (best 1 - 100 worst), indicating slightly worse than average price growth. NU’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 91 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 93 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: NU's P/B Ratio (4.237) is very high in comparison to the industry average of (1.271). P/E Ratio (15.620) is within average values for comparable stocks, (13.500). Projected Growth (PEG Ratio) (0.563) is also within normal values, averaging (1.190). Dividend Yield (0.000) settles around the average of (0.036) among similar stocks. P/S Ratio (5.149) is also within normal values, averaging (3.738).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NU’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 56, placing this stock worse than average.
BMA | ||
|---|---|---|
OUTLOOK RATING 1..100 | 70 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 15 Undervalued | |
PROFIT vs RISK RATING 1..100 | 2 | |
SMR RATING 1..100 | 1 | |
PRICE GROWTH RATING 1..100 | 76 | |
P/E GROWTH RATING 1..100 | 97 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| BMA | NU | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 81% | 1 day ago 74% |
| Stochastic ODDS (%) | 1 day ago 84% | 1 day ago 88% |
| Momentum ODDS (%) | 1 day ago 76% | 1 day ago 72% |
| MACD ODDS (%) | 1 day ago 90% | 1 day ago 64% |
| TrendWeek ODDS (%) | 1 day ago 76% | 1 day ago 68% |
| TrendMonth ODDS (%) | 1 day ago 79% | 1 day ago 63% |
| Advances ODDS (%) | 15 days ago 80% | 30 days ago 77% |
| Declines ODDS (%) | 3 days ago 78% | 8 days ago 67% |
| BollingerBands ODDS (%) | 1 day ago 64% | 1 day ago 86% |
| Aroon ODDS (%) | 1 day ago 81% | 1 day ago 62% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BMA’s FA Score shows that 3 FA rating(s) are green while NU’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BMA’s TA Score shows that 5 TA indicator(s) are bullish while NU’s TA Score has 4 bullish TA indicator(s).
BMA (@Regional Banks) experienced а -2.56% price change this week, while NU (@Regional Banks) price change was -6.37% for the same time period.
The average weekly price growth across all stocks in the @Regional Banks industry was -0.25%. For the same industry, the average monthly price growth was +0.62%, and the average quarterly price growth was +7.29%.
BMA is expected to report earnings on Nov 25, 2026.
NU is expected to report earnings on Nov 12, 2026.
Regional banks have a smaller reach than major banks, and cater mostly to one region of a country, such as a state or within a group of states. They offer services often similar – albeit with some limitations/smaller scale – compared to major banks. Taking deposits, making loans, mortgages, leases, credit cards , fund management, insurance and investment banking. SunTrust Banks, State Street Corp., M&T Bank Corp. are some examples of U.S. regional banks.
A.I.dvisor indicates that over the last year, BMA has been closely correlated with GGAL. These tickers have moved in lockstep 94% of the time. This A.I.-generated data suggests there is a high statistical probability that if BMA jumps, then GGAL could also see price increases.
| Ticker / NAME | Correlation To BMA | 1D Price Change % | ||
|---|---|---|---|---|
| BMA | 100% | +1.97% | ||
| GGAL - BMA | 94% Closely correlated | N/A | ||
| BBAR - BMA | 91% Closely correlated | +0.62% | ||
| SUPV - BMA | 89% Closely correlated | -1.64% | ||
| BSAC - BMA | 50% Loosely correlated | +0.82% | ||
| NU - BMA | 50% Loosely correlated | -0.09% | ||
More | ||||
A.I.dvisor indicates that over the last year, NU has been closely correlated with BBD. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if NU jumps, then BBD could also see price increases.